Routine Surgical Procedures During COVID-19 Pandemic: a French Nationwide Cohort Study

EPI-PHARE1 site in 1 country2,000,000 target enrollmentJanuary 1, 2019

ConditionsSurgery Cataract Hip Arthroplasty Knee Arthroplasty Coronary Stent Pacemaker COVID-19 Pandemic

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Surgery
Sponsor: EPI-PHARE
Enrollment: 2000000
Locations: 1
Primary Endpoint: observed and expected number
Status: Completed
Last Updated: 4 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

Determine the consequences of COVID-19 pandemic on routine targeted surgeries.

Five surgical procedures were considered : cataract surgery, hip and knee arthoplasties, coronary revascularisation by angioplasty and definitive cardiac stimulation.

The objective of the study is to quantify changes of these procedures in 2020 and in 2021 (up to June) compared to 2019 taking into account their annual evolution and according to the type of operation (primary or reoperation/revision) and emergency status, if applicable.

Registry

clinicaltrials.gov

Start Date

January 1, 2019

End Date

June 30, 2021

Last Updated

4 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

EPI-PHARE

Responsible Party

Principal Investigator

Emmanuelle Dufour

pharmacoepidemiologist, French National Agency for Medicines and Health Products Safety, French National Health Insurance

EPI-PHARE

Eligibility Criteria

Inclusion Criteria

•hospitalizations with at least one act of cataract surgey hip arthroplasty knee arthroplasty coronary angioplasty definitive cardiac stimulation (pacemaker)
•between January 1, 2019, and June 30, 2021